IFP TRANSCURE · TransCure - International Fellowship Program on Translational Research
7РП — „Хора“ (Действия „Мария Кюри“)
- Период
- 2012-05-01 → 2017-04-30
- Финансиране от ЕС
- 2 575 409 €
- Участници
- 1
- Схема
- MC-COFUND
Линиите свързват координатора с партньорите.
Накратко на български
Мембранните транспортери, като протеините от суперсемейството SLC, контролират пренасянето на вещества в клетките. Разбирането на тяхната структура и функция помага при изучаването на диабет, остеопороза, сърдечни и неврологични заболявания.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
TransCure - International Fellowship Program on Translational Research
The COFUND programme IFP TransCure covered years 2012-2017. This program has been fully integrated into the National Center of Competence in Research (NCCR) TransCure, a research network funded by the Swiss National Foundation dedicated to research in the field of membrane transporters and physiology. The NCCR TransCure is spread in five major Swiss Universities (University of Bern, University of Zurich, ETH Zurich, University of Lausanne and University of Basel). Out of the total 21 fellows who joined the program during these years, 20 worked in research groups based in Bern and 1 at ETHZ Zurich. All fellows could profit from the many networking opportunities across universities and from the interdisciplinary and international character of the network. The IFP fellows have been integrated in a vivid research network characterized by a strong interdisciplinary character and specialized training. The involved research groups have outstanding expertise in transport biology and physiology, chemistry and structural biology. Together, they aim to make progress in the understanding of membrane transport biology and chemistry. Importantly, the membrane transporters (~20) studied in the network are all relevant to prevalent human diseases such as diabetes, osteoporosis, heart and neurological diseases. The research carried out in these years led to several achievements. All the 21 participating fellows were integrated in the NCCR TransCure network characterised by an interdisciplinary approach where the structure, function, and/or pharmacology of specific membrane transporters was investigated. Most of the studied transporters were from the SLC superfamily of solute carriers, but also the TRPM4 ion channel and a, thus far, unknown endocannabinoid transport mechanism. Among the research highlights coming from the three approaches one should mention (1) the elucidation of the structure of the human ABCG2 transporter (published in Nature); (2) description of the evolution of old and new endocannabinoids in plants (published in Scientific reports); and (3) the report on the role of the TRPM4 channel in cardiac electrical disorders (published in Int. Journal of Cardiology). Altogether, already more than 20 original research papers were published with the IFP fellows as main or co-author (see attached table). Several manuscripts are in preparation. The research activity has been complemented by a comprehensive educational offer. Fellows could regularly attend seminars, scientific network events, retreats, specialised and soft skills courses and interdisciplinary project meetings. All these activities have been fostering the acquisition of new scientific and complementary skills. A survey conducted among the fellows towards the end of the program showed a high level of satisfaction about the program in general, since it represented a valuable opportunity to move forward in their scientific career. A summary of this survey is attached to this report. Further information on the NCCR TransCure network can be found on the website www.nccr-transcure.ch. A Twitter account of the program is also active (@NCCR_TransCure).
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
The herein proposed International Fellowship Program will be integrated into the recently funded Swiss translational research program, the National Center of Competence in Research (NCCR) TransCure, a joint research effort of 28 academic research groups located in major Swiss universities. The aim of the NCCR TransCure is to improve prevention and treatment of chronic diseases such as cancer, osteoporosis, neurodegenerative diseases, heart diseases, etc. Recent progresses in biomedical research have revealed that the dysfunction of specific membrane proteins contributes to the pathogenesis of these diseases. NCCR TransCure aims at studying the function of implicated membrane proteins and developing innovative drugs that control them in the diseased state.Membrane transport proteins and ion channels are particularly important pharmaceutical targets as they are the gatekeepers of the membranes of cells and cell organelles. In particular, they control the uptake and efflux of vital substances such as sugars, vitamins, trace elements, signal molecules and drugs. Targeting these proteins has been rather neglected yet by the pharmaceutical industry due to their structural complexity and hydrophobic nature. Thus, these proteins represent a large and unexplored pharmaceutical wealth. The TransCure premise is that integration of medicine, structural biology and chemistry will be tremendously beneficial in accelerating the translational avenue from ""gene to drug"".The future success of translational research in Europe depends on well-trained and multidisciplinary-oriented young researchers. The Swiss interdisciplinary TransCure research network represents the ideal platform for the training of such researchers from Europe and all over the world. Therefore, an integration of this COFUND IFP into TransCure will provide Europe with the long-sought ""next generation biomedical scientists"", necessary for the development of the ""next generation therapeutic drugs"" in the future.""
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSITAET BERN · BernКоординаторШвейцария
Връзки
Данни: CORDIS, © Европейски съюз
